We are live on !
Find out more
Brandywine Managers Portfolio holdings
AUM
$202M
Turnover
13.04%
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$75.2M
AUM Growth
+$2.53M
(+3.5%)
Cap. Flow
+$777K
Cap. Flow % of AUM
Cap. Flow %
1.03%
Top 10 Holdings %
Top 10 Hldgs %
67.76%
Holding
46
New
4
Increased
25
Reduced
3
Closed
–
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twilio
TWLO
|
+$930K |
| 2 |
CELL
PhenomeX Inc. Common Stock
CELL
|
+$728K |
| 3 |
Seer Inc
SEER
|
+$582K |
| 4 |
Schrodinger
SDGR
|
+$541K |
| 5 |
Relay Therapeutics
RLAY
|
+$508K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$5.96M |
| 2 |
Natera
NTRA
|
+$830K |
| 3 |
Twist Bioscience
TWST
|
+$328K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 37.93% |
| 2 | Technology | 27.58% |
| 3 | Healthcare | 24.85% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Keurig Dr Pepper
KDP
$48.2B
| $27.3M | 36.33% |
795,344
| – | – |
2020 Q4
1 quarter
|
|
|
2
DraftKings
DKNG
$9.5B
| $6.09M | 8.09% |
99,267
-99,267
| -50% | -$5.96M |
2020 Q3
2 quarters
|
|
|
3
Twilio
TWLO
$32.9B
| $3.33M | 4.43% |
9,782
+2,482
| +34% | +$930K |
2018 Q1
12 quarters
|
|
|
WORK
4
DELISTED
Slack Technologies, Inc.
WORK
| $2.87M | 3.81% |
70,530
| – | – |
2019 Q2
7 quarters
|
|
5
CrowdStrike
CRWD
$236B
| $2.62M | 3.48% |
57,444
+936
| +2% | +$49.5K |
2019 Q2
7 quarters
|
|
|
6
Twist Bioscience
TWST
$7.58B
| $2.08M | 2.77% |
16,828
-2,160
| -11% | -$328K |
2018 Q4
9 quarters
|
|
7
Okta
OKTA
$31.9B
| $2M | 2.65% |
9,050
| – | – |
2017 Q3
14 quarters
|
|
|
8
Natera
NTRA
$46.8B
| $1.84M | 2.45% |
18,121
-7,579
| -29% | -$830K |
2017 Q3
14 quarters
|
|
9
Guardant Health
GH
$20.9B
| $1.5M | 1.99% |
9,799
+2,699
| +38% | +$408K |
2018 Q4
9 quarters
|
|
10
Teladoc Health
TDOC
$1.58B
| $1.33M | 1.76% |
7,300
| – | – |
2017 Q3
14 quarters
|
|
11
10x Genomics
TXG
$7.79B
| $1.31M | 1.74% |
7,217
+2,917
| +68% | +$504K |
2019 Q3
6 quarters
|
|
12
Moderna
MRNA
$93.5B
| $1.24M | 1.65% |
9,510
+414
| +5% | +$60K |
2018 Q4
9 quarters
|
|
13
PagerDuty
PD
$1.24B
| $1.23M | 1.63% |
30,517
| – | – |
2019 Q2
7 quarters
|
|
14
Campbell Soup
CPB
$6.58B
| $1.21M | 1.6% |
24,014
| – | – |
2014 Q3
26 quarters
|
|
15
Zscaler
ZS
$31.5B
| $1.2M | 1.6% |
7,000
| – | – |
2018 Q4
9 quarters
|
|
|
16
Schrodinger
SDGR
$2.31B
| $1.18M | 1.56% |
15,420
+6,020
| +64% | +$541K |
2020 Q1
4 quarters
|
|
17
DocuSign
DOCU
$15B
| $1.12M | 1.48% |
5,511
+211
| +4% | +$48.9K |
2018 Q4
9 quarters
|
|
18
Quanterix
QTRX
$137M
| $1.09M | 1.45% |
18,678
+3,421
| +22% | +$231K |
2018 Q4
9 quarters
|
|
19
Veeva Systems
VEEV
$48.9B
| $1.01M | 1.35% |
3,876
+176
| +5% | +$49K |
2017 Q2
15 quarters
|
|
20
Beam Therapeutics
BEAM
$2.48B
| $886K | 1.18% |
11,067
+192
| +2% | +$18.3K |
2020 Q1
4 quarters
|
|
21
Intuitive Surgical
ISRG
$152B
| $861K | 1.14% |
3,495
+1,245
| +55% | +$313K |
2017 Q3
14 quarters
|
|
22
Varonis Systems
VRNS
$5.66B
| $826K | 1.1% |
16,080
+780
| +5% | +$46.2K |
2017 Q4
13 quarters
|
|
|
CELL
23
DELISTED
PhenomeX Inc. Common Stock
CELL
| $809K | 1.08% |
16,103
+10,684
| +197% | +$728K |
2020 Q3
2 quarters
|
|
|
24
Seer Inc
SEER
$87.6M
| $769K | 1.02% |
15,366
+9,945
| +183% | +$582K |
2020 Q4
1 quarter
|
|
|
25
Relay Therapeutics
RLAY
$4B
| $690K | 0.92% |
19,952
+11,702
| +142% | +$508K |
2020 Q3
2 quarters
|
|
Similar funds
OPL
LAMC
Brandywine Managers's Q1 2021 Portfolio in Review
As of Q1 2021, Brandywine Managers held 46 positions worth $75.2M, up 3.5% from $72.7M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Brandywine Managers's Q1 2021 filing shows 4 new, 25 increased and 3 reduced positions. Its largest new stake was Ionis Pharmaceuticals: 7,085 shares worth $319K. The largest sale was DraftKings, an estimated $5.96M.
By sector, the portfolio is most concentrated in Consumer Staples at 38% of assets, up from 36% a quarter earlier, followed by Technology and Healthcare.
- Brandywine Managers's largest Q1 2021 buy was Ionis Pharmaceuticals: 7,085 shares worth $319K.
- Brandywine Managers added most to Twilio in Q1 2021, an estimated $930K increase.
- Brandywine Managers's biggest Q1 2021 reduction was DraftKings, cutting an estimated $5.96M.
- Brandywine Managers's ten largest holdings make up 68% of its $75.2M portfolio in Q1 2021.
- Brandywine Managers opened 4 new positions and closed 0 in Q1 2021.
- Brandywine Managers's portfolio value rose 3.5% quarter-over-quarter to $75.2M.
Based on Brandywine Managers's 13F filing for Q1 2021, filed 13 May 2021.